PF-00277343 | m-entrepreneurship.com

Product Name :
PF-00277343

Search keywords :
PF-00277343

drugId :
null

Target Vo:
Thyroid hormone receptor

Target Vo Short Name :
THR

Moa_Name:
Thyroid hormone receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Alopecia

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STAT6 Antibody
DRP1 Antibody
CD90/Thy-1 Antibody: CD90/Thy-1 Antibody is an unconjugated, approximately 12 kDa, rabbit-derived, anti-CD90/Thy-1 polyclonal antibody. CD90/Thy-1 Antibody can be used for: WB, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, horse, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts